All news

Elevance beats estimates, lifts 2026 guidance

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Elevance Health reported third-quarter adjusted earnings per share of $6.99 and operating revenue of $50.4 billion, topping analyst expectations. The insurer raised full-year 2026 adjusted EPS guidance to at least $29.00 and lifted its operating cash flow outlook. Shares rose 1.1% after the announcement. Stronger Medicare Advantage and Individual ACA results support the earnings upgrade for investors.

Read original source

ELV company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.